How IVF became a licence to print money
By Fay Schopen,
The Guardian
| 06. 18. 2018
I don’t consider myself to be lucky. I have never won the lottery, or even found a fiver in an old coat pocket. But there is one aspect in life where fortune has smiled on me: I am eight months pregnant with my first child – the result of IVF treatment.
Around three-quarters of all IVF cycles fail. And results vary with age. Figures from the Human Fertilisation and Embryology Authority (HFEA) published in March state the average live birthrate for each fresh embryo transferred for women of all ages is 21%; for those aged under 35, it is 29% – the highest it has ever been. For older women, the picture is bleaker: 10% for women aged 40-42, for example.
In 2011, then aged 36, I underwent one cycle of IVF, funded by my local NHS trust, before I was treated for breast cancer. The embryos were frozen and in 2016 I embarked on the next stage: implantation. Funding was unavailable because I was by then over 40 and it was clear to me that IVF funding was unfair...
Related Articles
By Jeffrey Gettleman and Maya Tekeli, The New York Times | 09.24.2025
For some Greenlanders, sorry isn’t enough.
The prime minister of Denmark, Mette Frederiksen, made a special visit Wednesday to Greenland’s capital, Nuuk, to apologize in person for a traumatic chapter in Greenlandic history, when Danish doctors forced birth control on...
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...
Sir Francis Galton, 1890s, by Eveleen Myers (née Tennant)
npg.org
Public Domain via Wikipedia
As has been discussed in recent issues of Biopolitical Times (1, 2), there are, increasingly, companies that claim to be selling parents better babies by selecting the “best” embryos. These services don’t come cheap – think $50,000, or even more, for embryo testing, plus perhaps as much again for IVF and concomitant services. To most of us, that is extremely expensive...
By Margaux MacColl, The San Francisco Standard | 09.17.2025
Designer babies are coming soon to an IVF clinic near you.
Nucleus Genomics, founded by Kian Sadeghi in 2020, when he was just 20, got its start analyzing genomes to weigh a person’s risk of everything from cancer to ADHD...